<DOC>
	<DOCNO>NCT00695318</DOCNO>
	<brief_summary>This study compare safety efficacy Medidur FA treatment one eye sham-treated fellow eye subject geographic atrophy secondary AMD .</brief_summary>
	<brief_title>Fluocinolone Acetonide Intravitreal Inserts Geographic Atrophy</brief_title>
	<detailed_description>Each patient receive sham injection one eye active treatment eye . The eye receive active treatment select base randomization schedule .</detailed_description>
	<mesh_term>Macular Degeneration</mesh_term>
	<mesh_term>Atrophy</mesh_term>
	<mesh_term>Geographic Atrophy</mesh_term>
	<mesh_term>Fluocinolone Acetonide</mesh_term>
	<criteria>Clinical diagnosis bilateral GA secondary AMD ≥ 0.5 ≤ 7 MPS disc area Males nonpregnant females 55 year old old GA secondary condition AMD either eye History current CNV either eye need antiangiogenic therapy Glaucoma ocular hypertension ( IOP &gt; 21 mmHg OR concurrent therapy screen IOPlowering agent ) either eye Treatment intravitreal , subtenon , periocular steroid within 6 month prior enrollment either eye Any change systemic steroid therapy within 3 month screen History vitrectomy either eye Any ocular surgery within 12 week screen either eye</criteria>
	<gender>All</gender>
	<minimum_age>55 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2015</verification_date>
	<keyword>AMD</keyword>
	<keyword>Age-Related Macular Degeneration</keyword>
	<keyword>Geographic Atrophy</keyword>
	<keyword>GA</keyword>
</DOC>